No point stating the obvious now, but I can’t help myself. 2mg twice weekly dose is critical to our fortunes. Let’s hope Donna’s experience and our KOL’s have this at hand with regard to the FDA. Perhaps Paul’s unwavering belief in the molecule and its performance over the years of investigation (yrs 2000 onwards) will pay off. An interesting juncture. Ballsy by Paul to allow the FDA comb through our data with critcially low cash reserves. He is either crazy or brilliant.
We will find out, shortly.
Where we at?, page-364
-
- There are more pages in this discussion • 343 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $104.9M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 31.0¢ | 29.5¢ | $89.62K | 294.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 20607 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 16773 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |